A considerable amount of research indicates that the rat hepatitis E virus (ratHEV) may be entering humans more frequently than previously recognized. This emerging evidence raises essential questions regarding diagnosis, transmission, and the global burden of this neglected infection.
What is the Rat Hepatitis E Virus?
The rat hepatitis E virus, scientifically known as Rocahepevirus ratti, is a member of the Hepeviridae family. Recent studies highlight its potential as a zoonotic virus, which means it can be transmitted from animals, particularly rats, to humans.
Study Overview
A recent study published in Nature Communications reviewed the ecology, molecular virology, and clinical implications of ratHEV. Hepatitis E, a significant cause of acute hepatitis, registers approximately 19.5 million cases annually worldwide. Previously regarded as strictly rodent-restricted, human infections were confirmed only in 2018 when a liver transplant recipient in Hong Kong was found to carry ratHEV.
Clinical and Epidemiological Insights
- RatHEV has been identified in populations of black and Norwegian rats.
- Its RNA prevalence in these rats ranges between 10% and 30%, especially high in urban areas.
- Cases have been reported in Asia, Europe, and North America, underscoring its global reach.
Notable locations for ratHEV infections include China and Spain, with additional sporadic discoveries in countries like France, Canada, Germany, and Thailand.
Transmission Dynamics
Genotype C1 of ratHEV appears to pose the most significant zoonotic risk. Occasionally, infections have been recorded in carnivores, likely indicative of environmental contamination. While domestic pigs show signs of viral replication, their role as a definitive host remains uncertain.
Diagnosis Challenges
Diagnosing ratHEV infection can be difficult due to a lack of commercial assays. Currently, viral RNA detection is the leading method for confirming active infections. However, standard antibody assays used for HEV exhibit considerable cross-reactivity with ratHEV.
Clinical Outcomes
Infections range from asymptomatic to severe acute hepatitis, with potential progression to fulminant liver failure or chronic hepatitis, particularly in immunocompromised individuals. Extrahepatic manifestations such as encephalitis and glomerulonephritis have also been reported.
Public Health Implications
The understanding of ratHEV’s impact on human health remains limited. Enhancing surveillance measures and including ratHEV in hepatitis E guidelines could significantly improve diagnosis and research efforts. International collaboration is essential for developing effective diagnostic tools and strengthening the response to zoonotic threats.
